Non-benzenoid Aromatic Compounds for Hypoxic Phototherapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current phototherapeutic agents primarily rely on the Type 2 mechanism, which requires oxygen and has limitations, particularly in hypoxic environments, while Type 1 agents, which do not require oxygen, have been underdeveloped despite their potential for enhanced efficacy under such conditions.
Innovation Solution
Development of non-benzenoid aromatic compounds with specific substituent groups that allow for tailored spectral properties and photoreactivity, enabling targeted phototherapy through direct energy transfer mechanisms without the need for oxygen.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If Type 2 phototherapeutic agents are used, then therapeutic effect is achieved in normoxic conditions, but efficacy is reduced or lost in hypoxic environments
Solution Approach 1:
The patent changes the fundamental mechanism parameter from oxygen-dependent energy transfer (Type 2) to oxygen-independent electron transfer (Type 1). The non-benzenoid aromatic compounds are designed with specific molecular structures that enable direct electron transfer to photosensitizers, eliminating the requirement for molecular oxygen and thus maintaining therapeutic efficacy in hypoxic environments
Solution Approach 2:
The invention creates a composite phototherapeutic system combining non-benzenoid aromatic compounds (such as azulene derivatives) with photosensitizing agents. This composite approach allows the non-benzenoid compound to act as an electron donor that transfers electrons directly to the photosensitizer, generating reactive species without requiring oxygen, thereby complementing and enhancing traditional Type 2 phototherapeutic agents
2Device complexity
If traditional phototherapeutic mechanisms are used, then simplicity of mechanism is maintained, but therapeutic options are limited
Solution Approach 1:
The non-benzenoid aromatic compounds serve multiple functions: they act as electron donors, modulate spectral properties of photosensitizers, and can be tailored through substituent groups to achieve different photoreactivities. This multi-functionality expands therapeutic options while maintaining relative mechanistic simplicity through the unified Type 1 electron transfer pathway
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These compounds provide effective tissue damage in hypoxic conditions and offer a complementary approach to existing phototherapeutic methods, enhancing therapeutic options for clinicians by utilizing direct energy transfer mechanisms.
Implementation Method 1
enabling targeted phototherapy through direct energy transfer mechanisms without the need for oxygen
Data Source
AI summary
This invention is directed to non-benzenoid aromatic compounds. Other aspects include methods of using non-benzenoid aromatic compounds for imaging and phototherapeutic uses thereof. Non-benzenoid compounds provided herein generally have one or more substituent groups which allow tailoring of the spectral properties or provide photoreactivity or targeting ability.